Skip to main content
    C

    Creative Medical Technology Holdings Inc (CELZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.48
    -0.04 (-8.38%)

    Market Cap: $4.01M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Creative Medical Technology Holdings Inc (CELZ) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Creative Medical Technology Holdings (CELZ) has a market cap of $4.01M. It kept -248870.63% of revenue as net income over the last 12 months. Its share count is up 194.42% from a year earlier.

    Total Valuation

    Market Cap$4.01M
    Latest price (Nov 17, 2026)$0.48

    Key Dates

    The next earnings report is expected on Mar 18, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 18, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 15.24% in the quarter ended Sep 30, 2026 and grew 108.46% a year over 2 years.

    Shares Outstanding7.60M
    Shares Change (YoY)+194.42%
    Shares Change (QoQ)+15.24%
    Share Count Growth (2Y CAGR)+108.46%

    Valuation Ratios

    P/B Ratio0.5x
    P/TBV Ratio0.5x

    Price Statistics

    The stock is down 84.87% over 52 weeks and trades 40.00% below its 50-day average.

    Beta (1Y)1.56
    52-Week Change-84.87%
    1-Month Change-34.15%
    3-Month Change-57.46%
    6-Month Change-78.24%
    5-Year Change-99.10%
    10-Year Change-100.00%
    Total Return (1Y)-84.87%
    Total Return (3Y CAGR)-52.67%
    Total Return (5Y CAGR)-57.66%
    Max Drawdown (1Y)-84.38%
    Max Drawdown (3Y)-92.61%
    Sharpe Ratio (1Y)-1.45
    Correlation with SPY (1Y)0.17
    50-Day Average$0.80
    200-Day Average$1.49
    52-Week Range$0.52 to $3.15
    RSI (14 Days)25.8
    Average Volume (20 Days)88.97K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 23.66x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio23.66x
    Quick Ratio23.66x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -107.35% over the last 12 months, against a 5-year average of -18.69%.

    Return on Equity (ROE)-107.35%
    Return on Assets (ROA)-102.57%
    ROE (5Y Average)-18.69%
    ROA (5Y Average)-18.17%
    ROIC (5Y Average)-64.58%
    Asset Turnover0.00x
    Inventory Turnover0.02x

    Scores

    CELZ has an Altman Z-Score of -9.64, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-9.64
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $3.00K over the last 12 months is down 50.00% from the 12 months before.

    Revenue$3.00K
    Revenue Growth (YoY)-50.00%
    Gross Profit$2.01K
    Operating Income-$7.69M
    Pretax Income-$7.47M
    Net Income-$7.47M
    Reported EPS (TTM)-$1.99

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 95.47% of the $7.28M in total assets.

    Cash and Equivalents$6.85M
    Total Debt$0
    Net Cash$6.85M
    Net Cash Per Share$0.90
    Working Capital$6.64M
    Shareholder Equity$6.95M
    Book Value Per Share$0.92
    Tangible Book Value$6.62M
    Tangible Book Per Share$0.87
    Total Assets$7.28M
    Total Liabilities$293.23K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$6.40M
    FCF Per Share-$0.86
    Depreciation and Amortization$85.66K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -256435.00%.

    Gross Margin66.87%
    Operating Margin-256435.00%
    Pretax Margin-248870.63%
    Net Margin-248870.63%
    Gross Margin (5Y Average)59.33%

    Growth

    Revenue fell 59.24% a year over 3 years.

    Revenue Growth (3Y CAGR)-59.24%
    Revenue Growth (5Y CAGR)-48.43%
    Book Value Per Share Growth (2Y CAGR)-34.92%
    Tangible Book Per Share Growth (2Y CAGR)-35.31%

    Revenue and profit by year

    Dividends and Yields

    CELZ does not pay a dividend.

    Buyback Yield-112.07%
    Shareholder Yield-112.07%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jun 12, 2023.

    Last Split DateJun 12, 2023
    Split TypeReverse split
    Split Ratio1:10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CELZ

    What is CELZ's market cap?

    Creative Medical Technology Holdings has a market cap of $4.01M.

    How many shares of CELZ are outstanding?

    Creative Medical Technology Holdings has 7.60M shares outstanding. The count is up 194.42% from a year earlier.

    Does CELZ pay a dividend?

    No. Creative Medical Technology Holdings does not pay a dividend.

    How much debt does CELZ have?

    Creative Medical Technology Holdings has $0 of total debt and $6.85M of cash and equivalents, a net cash position of $6.85M.